Integra LifeSciences Holdings C

Historical 13F Holders

Symbol
IART
CUSIP
457985208
All holders as of
Q2 2026
Type
Equity
Class
COM NEW
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each filer's latest filing for 457985208 since 12/18/2024, largest first.

Filer % of Class Filed
BlackRock, Inc. 13G/A 13.2% 7/17/2025
Event 6/30/2025
Rubric Capital Management LP 13G/A
9.5% 7/9/2025
Event 6/30/2025
Vanguard Portfolio Management LLC 13G 5.0% 7/31/2026
Event 6/30/2026
Under 5%, checked the "5 percent or less" box, or amended by a later filing (5)
Fuller & Thaler Asset Management, Inc. 13G/A 4.7% 2/17/2026
Event 12/31/2025
Invesco Ltd. 13G/A 4.5% 11/6/2025
Event 9/30/2025
Morgan Stanley 13G/A 4.3% 8/5/2025
Event 6/30/2025
Vanguard Group Inc 13G/A 0% 3/27/2026
Event 3/13/2026
Paradigm Capital Management Inc/NY 13G/A
Checked 5% or less
8/13/2026
Event 3/31/2026

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q3 5 13.4 k $218 k
2026 Q2 215 74.8 M $1.39 B
2026 Q1 205 74.8 M $705 M
2025 Q4 210 77.7 M $966 M
2025 Q3 211 73.4 M $1.05 B
2025 Q2 215 73.8 M $905 M
2025 Q1 228 73.6 M $1.62 B
2024 Q4 229 69.3 M $1.57 B
2024 Q3 233 70.4 M $1.24 B
2024 Q2 251 77.5 M $2.26 B
2024 Q1 293 76.0 M $2.70 B
2023 Q4 292 73.0 M $3.18 B
2023 Q3 269 68.8 M $2.63 B
2023 Q2 295 69.2 M $2.85 B
2023 Q1 291 72.9 M $4.18 B
2022 Q4 295 77.2 M $4.32 B
2022 Q3 291 77.0 M $3.26 B
2022 Q2 293 73.1 M $3.95 B
2022 Q1 288 75.1 M $4.82 B
2021 Q4 292 77.4 M $5.19 B
2021 Q3 269 77.0 M $5.27 B
2021 Q2 271 74.8 M $5.10 B
2021 Q1 267 73.8 M $5.10 B
2020 Q4 268 77.5 M $5.03 B
2020 Q3 250 72.8 M $3.43 B
2020 Q2 282 72.3 M $3.40 B
2020 Q1 273 71.7 M $3.20 B
2019 Q4 290 71.5 M $4.17 B
2019 Q3 291 69.2 M $4.16 B
2019 Q2 274 70.8 M $3.96 B
2019 Q1 276 71.5 M $3.98 B
2018 Q4 262 72.4 M $3.27 B
2018 Q3 273 75.3 M $4.96 B
2018 Q2 267 72.8 M $4.69 B
2018 Q1 243 71.2 M $3.93 B
2017 Q4 226 71.4 M $3.42 B
2017 Q3 220 69.3 M $3.50 B
2017 Q2 228 66.8 M $3.63 B
2017 Q1 244 68.6 M $2.89 B
2016 Q4 235 34.8 M $2.97 B
2016 Q3 239 33.3 M $2.75 B
2016 Q2 216 33.5 M $2.67 B
2016 Q1 200 32.9 M $2.22 B
2015 Q4 192 32.4 M $2.19 B
2015 Q3 195 30.9 M $1.84 B
2015 Q2 192 27.1 M $1.83 B
2015 Q1 174 27.6 M $1.70 B
2014 Q4 166 26.7 M $1.45 B
2014 Q3 150 26.4 M $1.31 B
2014 Q2 153 26.6 M $1.25 B
2014 Q1 152 25.7 M $1.18 B